I am a Principal Investigator and Senior Research Fellow at the University of Auckland, New Zealand, and an Associate Investigator in the Maurice Wilkins Centre (Centre of Research Excellence). My research bridges synthetic chemistry, chemical biology, and translational medicine, focusing on developing next-generation antibody-drug conjugates (ADCs), radionuclide-antibody conjugates (RACs), and precision protein and peptide functionalization for targeted cancer therapy and molecular imaging. I hold the Health Research Council of New Zealand Sir Charles Hercus Research Fellowship, leading a multidisciplinary programme to develop multi-payload ADCs for ovarian cancer, integrating linker design, SAR studies, and bioconjugation chemistry to improve therapeutic efficacy and selectivity.